Diagnosis of infectious complications in patients with acute pancreatitis

Abstract

BACKGROUND: Up to 30% of patients with acute pancreatitis suffer from the severe form of the disease, of which 30% of cases are lethal, significantly rising to 80% at the development of infectious complications.

AIM: To improve treatment results of patients with acute pancreatitis due to early diagnostics of infectious complications.

MATERIALS AND METHODS: Expression of CD64 antigen on neutrophil membrane (DC64 index of neutrophils) was studied using a flow cytometer “Cytomics FC500” (Beckman Coulter, USA) using 3-color combination of direct monoclonal antibodies “Beckman Coulter”: СD14FITC/CD64PE/CD45PC5. Material was whole blood.

RESULTS: A direct correlation of moderate strength with the development of sepsis was found for both the procalcitonin value and C-reactive protein concentration at this period of illness. However, no relations of endogenous intoxication markers with the development of infectious complications were found (correlation coefficients less than 0.4). Thus, it should be noted that the difference in the indices of the studied parameters of the CD64 antigen expression in the groups began to increase exactly during the 2–3rd week of the disease.

CONCLUSION: Based on the literature data, we formulated a working hypothesis, which states that the degree of CD64 receptor expression on peripheral blood neutrophils is an early marker of infectious complications of acute pancreatitis. The value of average fluorescence intensity index of molecules CD64 equal to 10 conventional units was accepted as a threshold value with regard to the development of IE, and the value of 15 conventional unitsas a threshold value with regard to sepsis. The study was conducted in a prospective group of 28 patients. In accordance with the provision of the working hypothesis, the patients were divided into 3 groups depending on the level of average fluorescence intensity index of molecules CD64. Expression of the CD64 receptor on peripheral blood granulocytes as an early laboratory marker of infectious complications of the disease was studied for the first time. We determined sensitivity and specificity, optimal terms of the given research, detected regularities of CD64 expression changes in the course of acute pancreatitis, correlations with other clinical and laboratory indexes, including prospective markers of infection (procalcitonin, C-reactive protein), with the integral scales of severity estimation of patients with acute destructive pancreatitis. Determination of the level of the receptor CD64 expression on the peripheral blood neutrophils showed that this marker reflects the dynamics of the disease course and gives the possibility of the early diagnostics of the infectious complications of acute pancreatitis. The use of this method provides additional information about the development of the surgical infection. It is important that the changes of CD64 antigen expression in dynamics outrun other markers of systemic inflammatory response and sepsis. CD64 antigen expression data on peripheral blood neutrophils is an additional factor in determining differentiated surgical tactics in phase I of the disease’s development with regard to acute fluid collections in patients with acute pancreatitis.

Keywords

acute pancreatitis / diagnosis / early laboratory marker / infection marker / infectious complication / neutrophil CD64 index / sepsis

References

[1] Ministry of Health of the Russian Federation. Acute pancreatitis: clinical guidelines. Moscow; 2020. 38 p. (In Russ.)

[2] Министерство здравоохранения РФ. Острый панкреатит: клинические рекомендации. М., 2020. 38 с.

[3] Sukhina IA, Meshkova ME, Nikitin VYu, et al. Evaluation of CD64, HLA-DR antigen expression and cytokine levels in sepsis. Clinical Laboratory Diagnostics. 2016;(9):93. (In Russ.)

[4] Сухина И.А., Мешкова М.Е., Никитин В.Ю., и др. Оценка экспрессии антигенов CD64, HLA-DR и уровней цитокинов при сепсисе // Клиническая лабораторная диагностика. 2016. № 9. С. 93.

[5] Daryapeyma A, Pedersen G, Laxdal E, et al. Neutrophil CD64 as a marker for postoperative infection: a pilot study. Eur J Vasc Endovasc Surg. 2009;38(1):100–103. DOI: 10.1016/j.ejvs.2009.03.012

[6] Daryapeyma A., Pedersen G., Laxdal E., et al. Neutrophil CD64 as a Marker for Postoperative Infection: A Pilot Study // Eur. J. Vasc. Endovasc. Surg. 2009. Vol. 38, No. 1. P. 100–103. DOI: 10.1016/j.ejvs.2009.03.012

[7] Litvin AA, Rebrova OYu. Decision support systems in the diagnosis and treatment of acute pancreatitis. Health and Ecology Issues. 2016;(2(48)):10–17. (In Russ.)

[8] Литвин А.А., Реброва О.Ю. Системы поддержки принятия решений в диагностике и лечении острого панкреатита // Проблемы здоровья и экологии. 2016. № 2 (48). С. 10–17.

[9] Ivanov AM, Zhdanov KV, Krivoruchko AB. Prospective technologies and research in medical laboratory diagnostics. Military Medical Journal. 2013;334(6):54–57. (In Russ.)

[10] Иванов А.М., Жданов К.В., Криворучко А.Б. Перспективные технологии и исследования в области медицинской лабораторной диагностики // Военно-медицинский журнал. 2013. Т. 334, № 6. С. 54–57.

[11] Ivanusa SYa, Lazutkin MV, Chebotar’ AV. Diagnosis and prevention of infectious complications of acute pancreatitis. Bulletin of the Russian Military Medical Academy. 2019;(2):198–203. (In Russ.)

[12] Ивануса С.Я., Лазуткин М.В., Чеботарь А.В. Диагностика и профилактика инфекционных осложнений острого панкреатита // Вестник Российской Военно-медицинской академии. 2019. № 2. С. 198–203.

[13] El’skiy IK, Shirshov IV, Medvedev AV. Features of assessing the severity of acute necrotizing pancreatitis and their prognostic value. Vestnik neotlozhnoy i vosstanovitel’noy khirurgii. 2017;2(2–3):238–242. (In Russ.)

[14] Ельский И.К., Ширшов И.В., Медведев А.В. Особенности оценки тяжести острого некротического панкреатита и их прогностическое значение // Вестник неотложной и восстановительной хирургии. 2017. Т. 2, № 2–3. С. 238–242.

[15] Mantke R, Lippert H, Büchler MV, et al., eds. International Practices in Pancreatic Surgery. Heidelberg: Springer; 2013.

[16] Mantke R., Lippert H., Büchler M.V., et al., eds. International Practices in Pancreatic Surgery. Heidelberg: Springer, 2013.

[17] Kotiv BN, Ivanusa SYa, Dzidzava II, et al. Minimally invasive methods in prevention and treatment of infected pancreonecrosis. In: Vishnevskiy VA, Gal’perin EI, Stepanоva YuA, et al., ed. Materials of the Plenum of the Board of the Association of Hepatopancreatobiliary Surgeons of the CIS countries. Samara; 2015: 74–76. (In Russ.)

[18] Котив Б.Н., Ивануса С.Я., Дзидзава И.И., и др. Минимально инвазивные методы в профилактике и лечении инфицированного панкреонекроза. В сб. Вишневский В.А., Гальперин Э.И., Степанова Ю.А., и др. Материалы пленума правления Ассоциации гепатопанкреатобилиарных хирургов стран СНГ. Самара, 2015. С. 74–76.

[19] Zubarev PN, Kosachev ID, Paskar’ TV. Causes of fatal outcomes in acute destructive pancreatitis. Bulletin of St. Petersburg State University. Series 11, Medicine. 2009;(4):161–168. (In Russ.)

[20] Зубарев П.Н., Косачев И.Д., Паскарь Т.В. Причины летальных исходов при остром деструктивном панкреатите // Вестник СПбГУ. Сер. 11. Медицина. 2009. № 4. С. 161–168.

[21] Ermolov AS, Blagovestnov DA, Rogal’ ML, Omel´yanovich DA. Long-term results of treatment of severe acute pancreatitis. Khirurgiya. Zurnal im. N.I. Pirogova. 2016;(10):11–15. (In Russ.) DOI: 10.17116/hirurgia20161011-15

[22] Ермолов А.С., Благовестнов Д.А., Рогаль М.Л., Омельянович Д.А. Отдаленные результаты лечения тяжелого острого панкреатита // Хирургия. Журнал им. Н.И. Пирогова. 2016. № 10. С. 11–15. DOI: 10.17116/hirurgia20161011-15

[23] Hoffmann JJ. Neutrophil CD64 as a sepsis biomarker. Biochem. Med. 2011; 21(3): 282–290.

[24] Hoffmann J.J. Neutrophil CD64 as a sepsis biomarker // Biochem. Med. 2011. Vol. 21, No. 3. P. 282–290.

RIGHTS & PERMISSIONS

Sishchikov D.S., Alent’ev S.A.